Device Trial Radar · NCT03442231
Journey™ UNI Post Market Clinical Follow-Up
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
131
Actual
Start
Apr 11, 2018
Primary completion
Jan 25, 2024
Study completion Jan 25, 2024
Sponsor
- Lead sponsor
- Smith & Nephew, Inc.Public (SNN)
- Sponsor type
- Industry
- First posted
- Feb 22, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a retrospective/prospective, open-label single cohort, multicenter study to collect relevant clinical data from subjects with unicompartmental degeneration of the knee in whom the Journey UNI UKS was previously implanted.
Conditions
- Non-inflammatory Degenerative Joint Disease
Interventions
Journey UNI Unicompartmental Knee SystemDevice
Lateral or medial knee compartment replacement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Implant SurvivalTime frame: 5 years
Locations
4 sites in 2 countries. Site status is shown where the registry gives one.
Orthopaedic Specialists of Central Arizona-Scottsdale
Scottsdale, Arizona
Illinois Bone and Joint Institute
Park Ridge, Illinois
Tennessee Orthopedic Alliance, P.A.
Nashville, Tennessee
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.